Internal Medicine, Nephrology · Atlanta, GA
NPI
1336215037
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1860 Peachtree Rd NE
Atlanta, GA, 30309
Phone (404) 355-7219
Groups this clinician bills Medicare through
Medicare paid, 2024
$224K
2,885 services
Medicare patients, 2024
610
Average age 73
Drug cost, 2024
$1.0M
4,224 prescriptions
Company payments, 2025
$701
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael S Katz was code 99214 (office e&m - established), 783 times for 384 patients. In total Michael S Katz billed 2,885 services in 31 codes, and Medicare paid $224K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 783 | 384 | $92.37 | $72K |
| 81003 Clinical Chemistry | Office | 412 | 274 | $2.18 | $900 |
| 99232 Hospital E&M - Subsequent | Facility | 213 | 102 | $65.30 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 174 | 142 | $13.80 | $2,402 |
| 99458 E&M - Miscellaneous | Office | 172 | 16 | $33.24 | $5,717 |
| 90960 ESRD Related Services (not dialysis) | Office | 154 | 23 | $293.72 | $45K |
| 99457 E&M - Miscellaneous | Office | 123 | 19 | $40.96 | $5,038 |
| 99233 Hospital E&M - Subsequent | Facility | 107 | 66 | $99.30 | $11K |
| 99213 Office E&M - Established | Office | 88 | 59 | $62.30 | $5,483 |
| 99454 E&M - Miscellaneous | Office | 79 | 13 | $39.92 | $3,154 |
| 90966 ESRD Related Services (not dialysis) | Office | 63 | 17 | $241.86 | $15K |
| 90962 ESRD Related Services (not dialysis) | Office | 59 | 13 | $170.23 | $10K |
| 99205 Office E&M - New | Office | 55 | 55 | $152.11 | $8,366 |
| 99223 Hospital E&M - Initial | Facility | 50 | 47 | $142.84 | $7,142 |
| 90961 ESRD Related Services (not dialysis) | Office | 35 | 22 | $246.89 | $8,641 |
By year: 2022 $208K for 2,402 services; 2023 $213K for 2,762 services; 2024 $224K for 2,885 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 412 | 274 | $2.18 | $900 |
| 36415 Venipuncture Blood Collection | 15 | 15 | $8.65 | $130 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael S Katz prescribed most often to Medicare patients was Amlodipine Besylate, with 248 prescriptions and refills. In total Michael S Katz wrote 4,224 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 248 | 694 | 83 | $1,503 |
| Atorvastatin Calcium Generic | 156 | 406 | 43 | $1,523 |
| Farxiga Dapagliflozin Propanediol | 135 | 259 | 35 | $143K |
| Losartan Potassium Generic | 133 | 362 | 44 | $1,189 |
| Lisinopril Generic | 122 | 356 | 40 | $774 |
| Calcitriol Generic | 113 | 231 | 32 | $2,040 |
| Metoprolol Succinate Generic | 108 | 308 | 39 | $1,870 |
| Prednisone Generic | 106 | 293 | 33 | $941 |
| Allopurinol Generic | 105 | 290 | 32 | $961 |
| Furosemide Generic | 87 | 218 | 31 | $479 |
| Zolpidem Tartrate Generic | 75 | 75 | 12 | $376 |
| Carvedilol Generic | 72 | 171 | 24 | $435 |
| Simvastatin Generic | 71 | 214 | 20 | $620 |
| Nifedipine Er Nifedipine | 68 | 154 | 23 | $2,218 |
| Pantoprazole Sodium Generic | 68 | 182 | 23 | $997 |
Brand drugs: 620 claims; generic drugs: 3,587 claims; opioid claims: 46.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael S Katz $701 ($701 in general payments such as food, travel and fees) from 14 companies. The largest payer was Novartis Pharmaceuticals Corporation with $177.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 8 | $177 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $83.01 |
| Amgen Inc. AMGN | 4 | $72.02 |
| Scpharmaceuticals Inc. SCPH | 3 | $54.22 |
| Travere Therapeutics, Inc. TVTX | 5 | $48.84 |
| Vifor Pharma, Inc. | 2 | $47.54 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $45.06 |
| Ardelyx, Inc. ARDX | 2 | $37.67 |
| Novo Nordisk Inc NVO | 1 | $27.11 |
| Aurinia Pharma U.S., Inc. AUPH | 1 | $26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.